Shares of Acadia Pharmaceuticals Inc.( ACAD) fell by more than 25% on Monday after an article published on the CNN website raised concerns on the company’s lead drug, Nuplazid. The article termed the drug as ‘hostile’ and blamed it for the increasing deaths among patients that were treated with it.
Acadia Pharmaceuticals Shares Plunged Yesterday After A CNN Report
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться